By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency
Is AOD-9604 FDA-Approved
and has received grants in support of investigator and investigator-initiated trials from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, Astrazeneca, and Janssen
The GLOW Protocol typically features a compounded peptide formulation containing: GHK-Cu 10 mg BPC-157 3 mg TB-500 3.75 mg per mL This protocol is typically used as part of a 30-day regimen , though treatment recommendations may vary depending on the patient, goals, and provider guidance
My personal interest is in athletes with partial thickness or joint sided rotator cuff tears
It is recommended to check Hematocrit, reticulocyte count, vitamin B12, folate, and iron levels before treatment begins